We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Sciences Set to Acquire MYR GmbH for $1.4 Billion
Gilead Sciences Set to Acquire MYR GmbH for $1.4 Billion
Gilead Sciences has announced plans to purchase German biotech firm MYR GmbH for an estimated $1.4 billion (€1.15 billion), with the potential for additional milestone-based payments of up to $364.3 million (€300 million).